nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—UGT1A9—Irinotecan—colon cancer	0.295	0.382	CbGbCtD
Sulfamethoxazole—ALB—Irinotecan—colon cancer	0.0914	0.119	CbGbCtD
Sulfamethoxazole—ALB—Fluorouracil—colon cancer	0.0877	0.114	CbGbCtD
Sulfamethoxazole—CYP2C9—Capecitabine—colon cancer	0.0798	0.103	CbGbCtD
Sulfamethoxazole—CYP2C8—Fluorouracil—colon cancer	0.0678	0.0879	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—colon cancer	0.0484	0.0628	CbGbCtD
Sulfamethoxazole—CYP2C9—Fluorouracil—colon cancer	0.0473	0.0613	CbGbCtD
Sulfamethoxazole—CYP3A4—Irinotecan—colon cancer	0.0286	0.0372	CbGbCtD
Sulfamethoxazole—CYP3A4—Vincristine—colon cancer	0.025	0.0325	CbGbCtD
Sulfamethoxazole—NAT2—renal system—colon cancer	0.00728	0.12	CbGeAlD
Sulfamethoxazole—NAT1—bone marrow—colon cancer	0.00501	0.0824	CbGeAlD
Sulfamethoxazole—NAT1—vagina—colon cancer	0.0048	0.079	CbGeAlD
Sulfamethoxazole—NAT2—liver—colon cancer	0.00445	0.0732	CbGeAlD
Sulfamethoxazole—NAT1—liver—colon cancer	0.00405	0.0666	CbGeAlD
Sulfamethoxazole—UGT1A9—renal system—colon cancer	0.00393	0.0647	CbGeAlD
Sulfamethoxazole—Sulfanilamide—CA7—colon cancer	0.00379	0.891	CrCbGaD
Sulfamethoxazole—ALB—gall bladder—colon cancer	0.00378	0.0622	CbGeAlD
Sulfamethoxazole—UGT1A9—digestive system—colon cancer	0.00323	0.0531	CbGeAlD
Sulfamethoxazole—NAT1—lymph node—colon cancer	0.0031	0.0511	CbGeAlD
Sulfamethoxazole—PTGS1—endothelium—colon cancer	0.00248	0.0409	CbGeAlD
Sulfamethoxazole—UGT1A9—liver—colon cancer	0.0024	0.0395	CbGeAlD
Sulfamethoxazole—PTGS1—blood vessel—colon cancer	0.00229	0.0377	CbGeAlD
Sulfamethoxazole—Leukocytoclastic vasculitis—Methotrexate—colon cancer	0.00165	0.0101	CcSEcCtD
Sulfamethoxazole—Bone marrow depression—Capecitabine—colon cancer	0.00162	0.00984	CcSEcCtD
Sulfamethoxazole—Polyuria—Vincristine—colon cancer	0.00138	0.00843	CcSEcCtD
Sulfamethoxazole—Eruption—Methotrexate—colon cancer	0.00132	0.00804	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Fluorouracil—colon cancer	0.00129	0.00786	CcSEcCtD
Sulfamethoxazole—CYP2C8—renal system—colon cancer	0.00128	0.021	CbGeAlD
Sulfamethoxazole—Dermatitis exfoliative—Irinotecan—colon cancer	0.00125	0.00764	CcSEcCtD
Sulfamethoxazole—Renal impairment—Irinotecan—colon cancer	0.00124	0.00757	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Vincristine—colon cancer	0.00122	0.00743	CcSEcCtD
Sulfamethoxazole—Bone marrow depression—Methotrexate—colon cancer	0.0012	0.00733	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Irinotecan—colon cancer	0.00119	0.00724	CcSEcCtD
Sulfamethoxazole—Ataxia—Vincristine—colon cancer	0.00114	0.00696	CcSEcCtD
Sulfamethoxazole—PTGS1—epithelium—colon cancer	0.00111	0.0183	CbGeAlD
Sulfamethoxazole—ALB—liver—colon cancer	0.00111	0.0182	CbGeAlD
Sulfamethoxazole—PTGS1—smooth muscle tissue—colon cancer	0.00107	0.0177	CbGeAlD
Sulfamethoxazole—Ataxia—Fluorouracil—colon cancer	0.00106	0.00649	CcSEcCtD
Sulfamethoxazole—PTGS1—renal system—colon cancer	0.00103	0.017	CbGeAlD
Sulfamethoxazole—Pancreatitis—Irinotecan—colon cancer	0.001	0.00611	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Vincristine—colon cancer	0.000997	0.00607	CcSEcCtD
Sulfamethoxazole—Neutropenia—Vincristine—colon cancer	0.000981	0.00598	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Fluorouracil—colon cancer	0.000969	0.00591	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Vincristine—colon cancer	0.000958	0.00584	CcSEcCtD
Sulfamethoxazole—Neutropenia—Irinotecan—colon cancer	0.000956	0.00582	CcSEcCtD
Sulfamethoxazole—Pneumonia—Vincristine—colon cancer	0.000941	0.00574	CcSEcCtD
Sulfamethoxazole—Depression—Vincristine—colon cancer	0.000933	0.00569	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Fluorouracil—colon cancer	0.00093	0.00567	CcSEcCtD
Sulfamethoxazole—CYP2C9—digestive system—colon cancer	0.000929	0.0153	CbGeAlD
Sulfamethoxazole—CYP2C8—vagina—colon cancer	0.000924	0.0152	CbGeAlD
Sulfamethoxazole—Neuropathy peripheral—Vincristine—colon cancer	0.000917	0.00559	CcSEcCtD
Sulfamethoxazole—Pneumonia—Irinotecan—colon cancer	0.000917	0.00559	CcSEcCtD
Sulfamethoxazole—Stomatitis—Vincristine—colon cancer	0.000912	0.00556	CcSEcCtD
Sulfamethoxazole—Polyuria—Capecitabine—colon cancer	0.000901	0.00549	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Capecitabine—colon cancer	0.000901	0.00549	CcSEcCtD
Sulfamethoxazole—Renal failure—Irinotecan—colon cancer	0.000896	0.00546	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Fluorouracil—colon cancer	0.000893	0.00545	CcSEcCtD
Sulfamethoxazole—Stomatitis—Irinotecan—colon cancer	0.000888	0.00541	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Capecitabine—colon cancer	0.000885	0.00539	CcSEcCtD
Sulfamethoxazole—Glossitis—Methotrexate—colon cancer	0.000881	0.00537	CcSEcCtD
Sulfamethoxazole—Oliguria—Methotrexate—colon cancer	0.000881	0.00537	CcSEcCtD
Sulfamethoxazole—Pneumonia—Fluorouracil—colon cancer	0.000878	0.00535	CcSEcCtD
Sulfamethoxazole—Haemolytic anaemia—Capecitabine—colon cancer	0.000877	0.00534	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Fluorouracil—colon cancer	0.000873	0.00532	CcSEcCtD
Sulfamethoxazole—Infestation—Fluorouracil—colon cancer	0.000873	0.00532	CcSEcCtD
Sulfamethoxazole—CYP3A4—renal system—colon cancer	0.000864	0.0142	CbGeAlD
Sulfamethoxazole—Hepatic enzyme increased—Methotrexate—colon cancer	0.000858	0.00523	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Fluorouracil—colon cancer	0.000855	0.00521	CcSEcCtD
Sulfamethoxazole—Stomatitis—Fluorouracil—colon cancer	0.000851	0.00519	CcSEcCtD
Sulfamethoxazole—ALB—lymph node—colon cancer	0.00085	0.014	CbGeAlD
Sulfamethoxazole—PTGS1—digestive system—colon cancer	0.000848	0.014	CbGeAlD
Sulfamethoxazole—Dermatitis exfoliative—Capecitabine—colon cancer	0.000839	0.00511	CcSEcCtD
Sulfamethoxazole—Hallucination—Vincristine—colon cancer	0.000836	0.00509	CcSEcCtD
Sulfamethoxazole—Renal impairment—Capecitabine—colon cancer	0.000832	0.00507	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Vincristine—colon cancer	0.00083	0.00506	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Vincristine—colon cancer	0.000825	0.00503	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Vincristine—colon cancer	0.000823	0.00502	CcSEcCtD
Sulfamethoxazole—Purpura—Capecitabine—colon cancer	0.000821	0.005	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Fluorouracil—colon cancer	0.000814	0.00496	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Irinotecan—colon cancer	0.000804	0.0049	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Capecitabine—colon cancer	0.000795	0.00484	CcSEcCtD
Sulfamethoxazole—CYP2C8—liver—colon cancer	0.000779	0.0128	CbGeAlD
Sulfamethoxazole—Aplastic anaemia—Methotrexate—colon cancer	0.000762	0.00464	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Vincristine—colon cancer	0.000757	0.00461	CcSEcCtD
Sulfamethoxazole—PTGS1—vagina—colon cancer	0.000749	0.0123	CbGeAlD
Sulfamethoxazole—Ataxia—Capecitabine—colon cancer	0.000744	0.00454	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Irinotecan—colon cancer	0.000739	0.0045	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Irinotecan—colon cancer	0.000737	0.00449	CcSEcCtD
Sulfamethoxazole—Mental disorder—Vincristine—colon cancer	0.000736	0.00449	CcSEcCtD
Sulfamethoxazole—Chills—Irinotecan—colon cancer	0.000734	0.00447	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000713	0.00434	CcSEcCtD
Sulfamethoxazole—CYP3A4—digestive system—colon cancer	0.000708	0.0117	CbGeAlD
Sulfamethoxazole—CYP2C9—liver—colon cancer	0.000692	0.0114	CbGeAlD
Sulfamethoxazole—Photosensitivity—Methotrexate—colon cancer	0.000671	0.00409	CcSEcCtD
Sulfamethoxazole—Polyuria—Methotrexate—colon cancer	0.000671	0.00409	CcSEcCtD
Sulfamethoxazole—Vertigo—Vincristine—colon cancer	0.000657	0.004	CcSEcCtD
Sulfamethoxazole—Leukopenia—Vincristine—colon cancer	0.000655	0.00399	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Capecitabine—colon cancer	0.00065	0.00396	CcSEcCtD
Sulfamethoxazole—Vertigo—Irinotecan—colon cancer	0.00064	0.0039	CcSEcCtD
Sulfamethoxazole—Neutropenia—Capecitabine—colon cancer	0.00064	0.0039	CcSEcCtD
Sulfamethoxazole—Leukopenia—Irinotecan—colon cancer	0.000637	0.00389	CcSEcCtD
Sulfamethoxazole—Convulsion—Vincristine—colon cancer	0.000634	0.00386	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Methotrexate—colon cancer	0.000624	0.00381	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Capecitabine—colon cancer	0.000624	0.00381	CcSEcCtD
Sulfamethoxazole—Myalgia—Vincristine—colon cancer	0.000623	0.00379	CcSEcCtD
Sulfamethoxazole—Cough—Irinotecan—colon cancer	0.000621	0.00379	CcSEcCtD
Sulfamethoxazole—Pneumonia—Capecitabine—colon cancer	0.000613	0.00374	CcSEcCtD
Sulfamethoxazole—Leukopenia—Fluorouracil—colon cancer	0.00061	0.00372	CcSEcCtD
Sulfamethoxazole—Infestation—Capecitabine—colon cancer	0.00061	0.00372	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Capecitabine—colon cancer	0.00061	0.00372	CcSEcCtD
Sulfamethoxazole—Depression—Capecitabine—colon cancer	0.000608	0.00371	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000605	0.00369	CcSEcCtD
Sulfamethoxazole—Renal failure—Capecitabine—colon cancer	0.0006	0.00365	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Capecitabine—colon cancer	0.000598	0.00364	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Vincristine—colon cancer	0.000597	0.00364	CcSEcCtD
Sulfamethoxazole—Stomatitis—Capecitabine—colon cancer	0.000594	0.00362	CcSEcCtD
Sulfamethoxazole—Convulsion—Fluorouracil—colon cancer	0.000591	0.0036	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Vincristine—colon cancer	0.000585	0.00357	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Vincristine—colon cancer	0.000584	0.00356	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Irinotecan—colon cancer	0.000581	0.00354	CcSEcCtD
Sulfamethoxazole—Myalgia—Fluorouracil—colon cancer	0.000581	0.00354	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Capecitabine—colon cancer	0.000577	0.00352	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Irinotecan—colon cancer	0.00057	0.00347	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Capecitabine—colon cancer	0.000569	0.00347	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Irinotecan—colon cancer	0.000569	0.00347	CcSEcCtD
Sulfamethoxazole—Anorexia—Vincristine—colon cancer	0.000569	0.00347	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000557	0.00339	CcSEcCtD
Sulfamethoxazole—Anorexia—Irinotecan—colon cancer	0.000554	0.00338	CcSEcCtD
Sulfamethoxazole—Ataxia—Methotrexate—colon cancer	0.000554	0.00338	CcSEcCtD
Sulfamethoxazole—Hepatitis—Capecitabine—colon cancer	0.000547	0.00334	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Fluorouracil—colon cancer	0.000546	0.00333	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Fluorouracil—colon cancer	0.000545	0.00332	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000544	0.00331	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Capecitabine—colon cancer	0.000541	0.0033	CcSEcCtD
Sulfamethoxazole—Insomnia—Vincristine—colon cancer	0.00054	0.00329	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Capecitabine—colon cancer	0.000538	0.00328	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Capecitabine—colon cancer	0.000537	0.00327	CcSEcCtD
Sulfamethoxazole—Anorexia—Fluorouracil—colon cancer	0.000531	0.00323	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000531	0.00323	CcSEcCtD
Sulfamethoxazole—CYP3A4—liver—colon cancer	0.000528	0.00868	CbGeAlD
Sulfamethoxazole—Insomnia—Irinotecan—colon cancer	0.000526	0.0032	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vincristine—colon cancer	0.000519	0.00316	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Irinotecan—colon cancer	0.000518	0.00316	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Capecitabine—colon cancer	0.000518	0.00316	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Vincristine—colon cancer	0.000515	0.00314	CcSEcCtD
Sulfamethoxazole—Fatigue—Vincristine—colon cancer	0.000514	0.00314	CcSEcCtD
Sulfamethoxazole—Eye disorder—Capecitabine—colon cancer	0.000512	0.00312	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Irinotecan—colon cancer	0.000512	0.00312	CcSEcCtD
Sulfamethoxazole—Tinnitus—Capecitabine—colon cancer	0.00051	0.00311	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000507	0.00309	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Irinotecan—colon cancer	0.000505	0.00308	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Methotrexate—colon cancer	0.000504	0.00307	CcSEcCtD
Sulfamethoxazole—Insomnia—Fluorouracil—colon cancer	0.000503	0.00307	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000502	0.00306	CcSEcCtD
Sulfamethoxazole—Fatigue—Irinotecan—colon cancer	0.000501	0.00305	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methotrexate—colon cancer	0.000499	0.00304	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Fluorouracil—colon cancer	0.000496	0.00302	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Capecitabine—colon cancer	0.000495	0.00301	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Capecitabine—colon cancer	0.000493	0.00301	CcSEcCtD
Sulfamethoxazole—Chills—Capecitabine—colon cancer	0.000491	0.00299	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Fluorouracil—colon cancer	0.00049	0.00299	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Vincristine—colon cancer	0.000488	0.00297	CcSEcCtD
Sulfamethoxazole—PTGS1—lymph node—colon cancer	0.000484	0.00797	CbGeAlD
Sulfamethoxazole—Decreased appetite—Fluorouracil—colon cancer	0.000484	0.00295	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Methotrexate—colon cancer	0.000484	0.00295	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000481	0.00293	CcSEcCtD
Sulfamethoxazole—Mental disorder—Capecitabine—colon cancer	0.00048	0.00292	CcSEcCtD
Sulfamethoxazole—Malnutrition—Capecitabine—colon cancer	0.000477	0.0029	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—colon cancer	0.000476	0.0029	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000475	0.0029	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Vincristine—colon cancer	0.000472	0.00288	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vincristine—colon cancer	0.000472	0.00288	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—colon cancer	0.000465	0.00283	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—colon cancer	0.000464	0.109	CrCbGaD
Sulfamethoxazole—Body temperature increased—Irinotecan—colon cancer	0.000459	0.0028	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Irinotecan—colon cancer	0.000459	0.0028	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—colon cancer	0.000457	0.00278	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—colon cancer	0.000454	0.00277	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—colon cancer	0.000454	0.00277	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—colon cancer	0.000453	0.00276	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00045	0.00274	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—colon cancer	0.000446	0.00272	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—colon cancer	0.000443	0.0027	CcSEcCtD
Sulfamethoxazole—Urticaria—Fluorouracil—colon cancer	0.000442	0.0027	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Fluorouracil—colon cancer	0.00044	0.00268	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vincristine—colon cancer	0.00044	0.00268	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—colon cancer	0.000429	0.00262	CcSEcCtD
Sulfamethoxazole—Vertigo—Capecitabine—colon cancer	0.000428	0.00261	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Irinotecan—colon cancer	0.000428	0.00261	CcSEcCtD
Sulfamethoxazole—Asthenia—Vincristine—colon cancer	0.000428	0.00261	CcSEcCtD
Sulfamethoxazole—Leukopenia—Capecitabine—colon cancer	0.000427	0.0026	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—colon cancer	0.000424	0.00258	CcSEcCtD
Sulfamethoxazole—Asthenia—Irinotecan—colon cancer	0.000417	0.00254	CcSEcCtD
Sulfamethoxazole—Cough—Capecitabine—colon cancer	0.000416	0.00253	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Fluorouracil—colon cancer	0.00041	0.0025	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vincristine—colon cancer	0.000408	0.00249	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—colon cancer	0.000408	0.00248	CcSEcCtD
Sulfamethoxazole—Myalgia—Capecitabine—colon cancer	0.000406	0.00247	CcSEcCtD
Sulfamethoxazole—Arthralgia—Capecitabine—colon cancer	0.000406	0.00247	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000403	0.00246	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—colon cancer	0.000402	0.00245	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—colon cancer	0.0004	0.00244	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Irinotecan—colon cancer	0.000398	0.00242	CcSEcCtD
Sulfamethoxazole—Dizziness—Vincristine—colon cancer	0.000395	0.00241	CcSEcCtD
Sulfamethoxazole—Pruritus—Fluorouracil—colon cancer	0.000394	0.0024	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—colon cancer	0.000385	0.00235	CcSEcCtD
Sulfamethoxazole—Dizziness—Irinotecan—colon cancer	0.000384	0.00234	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Capecitabine—colon cancer	0.000381	0.00233	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—colon cancer	0.000381	0.00232	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Fluorouracil—colon cancer	0.000381	0.00232	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Capecitabine—colon cancer	0.000381	0.00232	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—colon cancer	0.00038	0.00232	CcSEcCtD
Sulfamethoxazole—Vomiting—Vincristine—colon cancer	0.000379	0.00231	CcSEcCtD
Sulfamethoxazole—Skin disorder—Capecitabine—colon cancer	0.000378	0.0023	CcSEcCtD
Sulfamethoxazole—Rash—Vincristine—colon cancer	0.000376	0.00229	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vincristine—colon cancer	0.000376	0.00229	CcSEcCtD
Sulfamethoxazole—Headache—Vincristine—colon cancer	0.000374	0.00228	CcSEcCtD
Sulfamethoxazole—Anorexia—Capecitabine—colon cancer	0.000371	0.00226	CcSEcCtD
Sulfamethoxazole—Vomiting—Irinotecan—colon cancer	0.00037	0.00225	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—colon cancer	0.000368	0.00224	CcSEcCtD
Sulfamethoxazole—Dizziness—Fluorouracil—colon cancer	0.000368	0.00224	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—colon cancer	0.000367	0.00224	CcSEcCtD
Sulfamethoxazole—Rash—Irinotecan—colon cancer	0.000366	0.00223	CcSEcCtD
Sulfamethoxazole—Dermatitis—Irinotecan—colon cancer	0.000366	0.00223	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—colon cancer	0.000366	0.00223	CcSEcCtD
Sulfamethoxazole—Headache—Irinotecan—colon cancer	0.000364	0.00222	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—colon cancer	0.000357	0.00218	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—colon cancer	0.000355	0.00216	CcSEcCtD
Sulfamethoxazole—Nausea—Vincristine—colon cancer	0.000354	0.00216	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000354	0.00216	CcSEcCtD
Sulfamethoxazole—Vomiting—Fluorouracil—colon cancer	0.000354	0.00216	CcSEcCtD
Sulfamethoxazole—Insomnia—Capecitabine—colon cancer	0.000352	0.00214	CcSEcCtD
Sulfamethoxazole—Rash—Fluorouracil—colon cancer	0.000351	0.00214	CcSEcCtD
Sulfamethoxazole—Dermatitis—Fluorouracil—colon cancer	0.000351	0.00214	CcSEcCtD
Sulfamethoxazole—Headache—Fluorouracil—colon cancer	0.000349	0.00213	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Capecitabine—colon cancer	0.000347	0.00211	CcSEcCtD
Sulfamethoxazole—Nausea—Irinotecan—colon cancer	0.000345	0.0021	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Capecitabine—colon cancer	0.000342	0.00209	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Capecitabine—colon cancer	0.000338	0.00206	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000336	0.00205	CcSEcCtD
Sulfamethoxazole—Fatigue—Capecitabine—colon cancer	0.000335	0.00204	CcSEcCtD
Sulfamethoxazole—Nausea—Fluorouracil—colon cancer	0.000331	0.00202	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—colon cancer	0.000319	0.00194	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000318	0.00194	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—colon cancer	0.000318	0.00194	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—colon cancer	0.00031	0.00189	CcSEcCtD
Sulfamethoxazole—Urticaria—Capecitabine—colon cancer	0.000309	0.00188	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Capecitabine—colon cancer	0.000307	0.00187	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Capecitabine—colon cancer	0.000307	0.00187	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—colon cancer	0.000307	0.00187	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—colon cancer	0.000302	0.00184	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—colon cancer	0.000302	0.00184	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.0003	0.00183	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—colon cancer	0.00029	0.00176	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Capecitabine—colon cancer	0.000287	0.00175	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—colon cancer	0.000284	0.00173	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—colon cancer	0.000284	0.00173	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—colon cancer	0.000281	0.00171	CcSEcCtD
Sulfamethoxazole—Asthenia—Capecitabine—colon cancer	0.000279	0.0017	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—colon cancer	0.000276	0.00168	CcSEcCtD
Sulfamethoxazole—Pruritus—Capecitabine—colon cancer	0.000275	0.00168	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Capecitabine—colon cancer	0.000266	0.00162	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000264	0.00161	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—colon cancer	0.000262	0.0016	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—colon cancer	0.000258	0.00157	CcSEcCtD
Sulfamethoxazole—Dizziness—Capecitabine—colon cancer	0.000257	0.00157	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—colon cancer	0.000255	0.00155	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—colon cancer	0.000252	0.00153	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—colon cancer	0.00025	0.00152	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—colon cancer	0.00025	0.00152	CcSEcCtD
Sulfamethoxazole—Vomiting—Capecitabine—colon cancer	0.000247	0.00151	CcSEcCtD
Sulfamethoxazole—Rash—Capecitabine—colon cancer	0.000245	0.00149	CcSEcCtD
Sulfamethoxazole—Dermatitis—Capecitabine—colon cancer	0.000245	0.00149	CcSEcCtD
Sulfamethoxazole—Headache—Capecitabine—colon cancer	0.000244	0.00149	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—colon cancer	0.000237	0.00144	CcSEcCtD
Sulfamethoxazole—Nausea—Capecitabine—colon cancer	0.000231	0.00141	CcSEcCtD
Sulfamethoxazole—Urticaria—Methotrexate—colon cancer	0.00023	0.0014	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—colon cancer	0.000229	0.0014	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—colon cancer	0.000229	0.0014	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—colon cancer	0.000213	0.0013	CcSEcCtD
Sulfamethoxazole—Asthenia—Methotrexate—colon cancer	0.000208	0.00127	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—colon cancer	0.000205	0.00125	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—colon cancer	0.000198	0.00121	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—colon cancer	0.000191	0.00117	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—colon cancer	0.000184	0.00112	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—colon cancer	0.000183	0.00111	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—colon cancer	0.000182	0.00111	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—colon cancer	0.000181	0.00111	CcSEcCtD
Sulfamethoxazole—Nausea—Methotrexate—colon cancer	0.000172	0.00105	CcSEcCtD
Sulfamethoxazole—NAT2—Metapathway biotransformation—CHST4—colon cancer	9.33e-06	0.138	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metapathway biotransformation—CHST5—colon cancer	4.28e-06	0.0635	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CHST4—colon cancer	3.25e-06	0.0481	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CA7—colon cancer	2.95e-06	0.0438	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Irinotecan Pathway—APC—colon cancer	2.14e-06	0.0318	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—BAX—colon cancer	1.8e-06	0.0266	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CHST5—colon cancer	1.79e-06	0.0265	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—ODC1—colon cancer	1.79e-06	0.0265	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	1.71e-06	0.0253	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	1.53e-06	0.0227	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CHST5—colon cancer	1.49e-06	0.0221	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	1.39e-06	0.0206	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—colon cancer	1.33e-06	0.0197	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	1.31e-06	0.0195	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CA7—colon cancer	1.23e-06	0.0182	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	1.09e-06	0.0161	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—PTGS2—colon cancer	1.04e-06	0.0154	CbGpPWpGaD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	9.97e-07	0.0148	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	9.18e-07	0.0136	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—CCND1—colon cancer	8.96e-07	0.0133	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Eicosanoid Synthesis—PTGS2—colon cancer	8.61e-07	0.0128	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	7.85e-07	0.0116	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CHST5—colon cancer	7.43e-07	0.011	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ODC1—colon cancer	7.43e-07	0.011	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	7.21e-07	0.0107	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	7.19e-07	0.0107	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—MYC—colon cancer	7.18e-07	0.0106	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.57e-07	0.00974	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	6.39e-07	0.00947	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.26e-07	0.00928	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Irinotecan Pathway—APC—colon cancer	6.05e-07	0.00898	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	5.22e-07	0.00774	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	5.08e-07	0.00753	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	4.79e-07	0.0071	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—ABCB1—colon cancer	4.73e-07	0.00701	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—TYMS—colon cancer	4.64e-07	0.00688	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	4.54e-07	0.00673	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	4.45e-07	0.0066	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.36e-07	0.00646	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	4.34e-07	0.00643	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CA7—colon cancer	4.27e-07	0.00633	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	4.21e-07	0.00625	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	4.13e-07	0.00612	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—PPARG—colon cancer	3.97e-07	0.00589	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	3.89e-07	0.00577	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CA7—colon cancer	3.48e-07	0.00516	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PPARG—colon cancer	3.29e-07	0.00488	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	3.09e-07	0.00459	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	3.05e-07	0.00452	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.87e-07	0.00426	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	2.68e-07	0.00397	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—EP300—colon cancer	2.6e-07	0.00385	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTGS2—colon cancer	2.59e-07	0.00384	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ODC1—colon cancer	2.59e-07	0.00383	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CHST5—colon cancer	2.59e-07	0.00383	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	2.54e-07	0.00377	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	2.52e-07	0.00373	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CA7—colon cancer	2.25e-07	0.00333	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CA7—colon cancer	2.23e-07	0.00331	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—EP300—colon cancer	2.15e-07	0.00319	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ODC1—colon cancer	2.11e-07	0.00312	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CHST5—colon cancer	2.11e-07	0.00312	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ABCB1—colon cancer	1.96e-07	0.00291	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	1.96e-07	0.0029	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—TYMS—colon cancer	1.93e-07	0.00286	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CA7—colon cancer	1.83e-07	0.00271	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFB1—colon cancer	1.8e-07	0.00267	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	1.75e-07	0.0026	CbGpPWpGaD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	1.71e-07	0.00254	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—colon cancer	1.66e-07	0.00247	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CA—colon cancer	1.59e-07	0.00236	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	1.58e-07	0.00235	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—TGFB1—colon cancer	1.53e-07	0.00226	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—colon cancer	1.47e-07	0.00217	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	1.45e-07	0.00216	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PPARG—colon cancer	1.37e-07	0.00202	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ODC1—colon cancer	1.36e-07	0.00202	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CHST5—colon cancer	1.36e-07	0.00202	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CHST5—colon cancer	1.35e-07	0.00201	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ODC1—colon cancer	1.35e-07	0.00201	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—AKT1—colon cancer	1.3e-07	0.00193	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA7—colon cancer	1.21e-07	0.00179	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ODC1—colon cancer	1.11e-07	0.00164	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CHST5—colon cancer	1.11e-07	0.00164	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTGS2—colon cancer	1.07e-07	0.00159	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.07e-07	0.00158	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—EP300—colon cancer	8.94e-08	0.00132	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.7e-08	0.00129	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.4e-08	0.00124	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	7.64e-08	0.00113	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	7.58e-08	0.00112	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	7.38e-08	0.00109	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ODC1—colon cancer	7.31e-08	0.00108	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CHST5—colon cancer	7.31e-08	0.00108	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.98e-08	0.00104	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.84e-08	0.00101	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ABCB1—colon cancer	6.83e-08	0.00101	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	6.77e-08	0.001	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—TYMS—colon cancer	6.71e-08	0.000995	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CA—colon cancer	6.61e-08	0.00098	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	5.76e-08	0.000854	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.69e-08	0.000844	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.62e-08	0.000833	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.59e-08	0.000828	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCB1—colon cancer	5.57e-08	0.000826	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TYMS—colon cancer	5.47e-08	0.000811	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—colon cancer	5.4e-08	0.000801	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.17e-08	0.000766	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARG—colon cancer	4.75e-08	0.000705	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	4.71e-08	0.000698	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.57e-08	0.000678	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.42e-08	0.000655	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.4e-08	0.000652	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.21e-08	0.000624	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EP300—colon cancer	4.02e-08	0.000595	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SRC—colon cancer	3.91e-08	0.000579	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARG—colon cancer	3.87e-08	0.000574	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—colon cancer	3.8e-08	0.000564	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NRAS—colon cancer	3.76e-08	0.000557	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—colon cancer	3.74e-08	0.000554	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.68e-08	0.000545	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.66e-08	0.000542	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.6e-08	0.000533	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCB1—colon cancer	3.6e-08	0.000533	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCB1—colon cancer	3.58e-08	0.00053	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TYMS—colon cancer	3.53e-08	0.000524	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TYMS—colon cancer	3.51e-08	0.000521	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—colon cancer	3.49e-08	0.000517	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—colon cancer	3.23e-08	0.000479	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—EP300—colon cancer	3.11e-08	0.000461	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—colon cancer	3.05e-08	0.000452	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.99e-08	0.000444	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—colon cancer	2.97e-08	0.00044	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCB1—colon cancer	2.93e-08	0.000434	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TYMS—colon cancer	2.88e-08	0.000426	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—colon cancer	2.87e-08	0.000426	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HRAS—colon cancer	2.75e-08	0.000407	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.72e-08	0.000403	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.7e-08	0.000401	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—EP300—colon cancer	2.54e-08	0.000376	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARG—colon cancer	2.5e-08	0.000371	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARG—colon cancer	2.49e-08	0.000369	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—colon cancer	2.43e-08	0.00036	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—colon cancer	2.3e-08	0.000341	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.21e-08	0.000328	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARG—colon cancer	2.04e-08	0.000302	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—colon cancer	1.97e-08	0.000292	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—colon cancer	1.96e-08	0.00029	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCB1—colon cancer	1.93e-08	0.000286	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TYMS—colon cancer	1.9e-08	0.000281	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—colon cancer	1.88e-08	0.000279	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—colon cancer	1.88e-08	0.000278	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—EP300—colon cancer	1.64e-08	0.000243	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—EP300—colon cancer	1.63e-08	0.000241	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—colon cancer	1.6e-08	0.000238	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—colon cancer	1.53e-08	0.000227	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARG—colon cancer	1.34e-08	0.000199	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—EP300—colon cancer	1.33e-08	0.000198	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—colon cancer	1.21e-08	0.00018	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—colon cancer	1.2e-08	0.000179	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—colon cancer	1.06e-08	0.000157	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—colon cancer	9.9e-09	0.000147	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—colon cancer	9.86e-09	0.000146	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—colon cancer	9.84e-09	0.000146	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—EP300—colon cancer	8.79e-09	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—colon cancer	8.05e-09	0.000119	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—colon cancer	6.5e-09	9.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—colon cancer	5.31e-09	7.87e-05	CbGpPWpGaD
